Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

8.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.1K
Intramolecular Claisen Condensation of Dicarboxylic Esters: Dieckmann Cyclization01:13

Intramolecular Claisen Condensation of Dicarboxylic Esters: Dieckmann Cyclization

3.3K
Dieckmann cyclization is an intramolecular Claisen condensation of diesters. The reaction occurs in the presence of a base and generates a cyclic β-ketoester as the final product. Commonly, 1, 6 and 1, 7-diesters are preferred substrates for the reaction since the generated five, and six-membered cyclic β-keto esters are particularly more stable.
3.3K
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

1.3K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.3K
Preventive Healthcare Services01:30

Preventive Healthcare Services

2.1K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.1K
Aggregates Classification01:29

Aggregates Classification

1.0K
Aggregate classification is generally based on its size, petrographic characteristics, weight, and source. Size classification ranges from coarse to fine aggregates, defined by the size of the particles. Coarse aggregates are particles that do not pass through ASTM sieve No. 4, and aggregates that pass through the sieve are fine aggregates.
Petrographic classification groups aggregates based on common mineralogical characteristics. Some of the common mineral groups found in aggregates are...
1.0K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

1.9K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic Code Expansion for Site-Specific Encoding of a Switchable, Intrinsic Fluorophore-Quencher Pair to Monitor Protein Dynamics.

bioRxiv : the preprint server for biology·2026
Same author

N-Terminal Amine Chemistry Influences α-Synuclein Interactions with Lipid Bilayers.

Biochemistry·2026
Same author

BioMatics 1.0: A Wasserstein Distance Approach for Next-Generation Multiple Sequence Alignment.

Proteins·2026
Same author

Genetic Code Expansion, Enzymatic Modification, and C-Terminal Labeling Enable Facile Production of Highly Modified α-Synuclein.

bioRxiv : the preprint server for biology·2026
Same author

Extending the classical sequence-structure-function paradigm through protein dynamics and context-dependent behavior.

FEBS letters·2026
Same author

IMMUND: A Diagnostic and Therapeutic Pipeline to Uncover the Convergence in Functional Perturbation at Early Stages of Neurodegenerative Diseases and Multiple Sclerosis Based on Protein Markers.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Jan 28, 2026

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.7K

Cyclized NDGA modifies dynamic α-synuclein monomers preventing aggregation and toxicity.

Malcolm J Daniels1, J Brucker Nourse2, Hanna Kim2

  • 1Pharmacology Graduate Group, Raymond and Ruth Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.

Scientific Reports
|March 1, 2019
PubMed
Summary

Novel nordihydroguaiaretic acid (NDGA) analogs prevent toxic α-synuclein aggregation, a key process in Parkinson's disease (PD). These compounds stabilize non-aggregating protein forms, offering a potential therapeutic strategy for PD and related neurodegenerative disorders.

More Related Videos

Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

1.1K
Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

22.6K

Related Experiment Videos

Last Updated: Jan 28, 2026

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.7K
Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

1.1K
Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

22.6K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • α-synuclein aggregation is a central mechanism in Parkinson's disease (PD) pathogenesis.
  • Inhibiting this aggregation is a key therapeutic goal for PD and related disorders.

Purpose of the Study:

  • To explore the molecular mechanisms by which novel nordihydroguaiaretic acid (NDGA) analogs inhibit α-synuclein aggregation.
  • To assess the therapeutic potential of NDGA analogs in a model of Parkinson's disease.

Main Methods:

  • Biochemical and biophysical assays to study α-synuclein aggregation.
  • In vitro studies using NDGA analogs and α-synuclein.
  • Neurodegeneration assays in Caenorhabditis elegans.

Main Results:

  • NDGA analogs induced compaction of monomeric α-synuclein, preventing amyloid fibril formation.
  • Oxidation-dependent cyclization of NDGA was crucial for its interaction with α-synuclein.
  • NDGA-pretreated α-synuclein resisted aggregation and inhibited aggregation of untreated α-synuclein.
  • Cyclized NDGA reduced α-synuclein-induced neurodegeneration in C. elegans.

Conclusions:

  • NDGA analogs stabilize aggregation-resistant α-synuclein monomers.
  • These compounds preserve functional α-synuclein conformations.
  • NDGA analogs represent a promising platform for developing novel Parkinson's disease therapies.